AAV9-HGF cooperating with TGF-beta/Smad inhibitor attenuates silicosis fibrosis via inhibiting ferroptosis
Authors:
Open Access
- 16 March 2023
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 161, 114537
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Ningxia Province (2022AAC03128)
- Natural Science Foundation of Ningxia Province (2022AAC05025)
- Key Research and Development Program of Ningxia (2018YBZD1497)
- Key Research and Development Program of Ningxia (2020BEG03008)
- Key Research and Development Program of Ningxia (2020BFH02003)
- National Natural Science Foundation of China (81960018)
- National Natural Science Foundation of China (82060264)
- National Natural Science Foundation of China (82160088)
- Ningxia Medical University (XM2019127)
- Ningxia Medical University (XT2018012)
- Ningxia Medical University (XT2018015)
- Ningxia Medical University (XT2020021)
This publication has 29 references indexed in Scilit:
- Controlled release strategies for rAAV-mediated gene deliveryActa Biomaterialia, 2016
- Ferroptosis as a p53-mediated activity during tumour suppressionNature, 2015
- Vascular Endothelial Growth Factor Promotes Fibrosis Resolution and Repair in MiceGastroenterology, 2014
- TGF-β Signaling Mediates Endothelial-to-Mesenchymal Transition (EndMT) During Vein Graft RemodelingScience Translational Medicine, 2014
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosisExpert Opinion on Investigational Drugs, 2013
- Targeted Gene Transfer of Hepatocyte Growth Factor to Alveolar Type II Epithelial Cells Reduces Lung Fibrosis in RatsHuman Gene Therapy, 2013
- SilicosisThe Lancet, 2012
- Hepatocyte growth factor in lung repair and pulmonary fibrosisActa Pharmacologica Sinica, 2010
- Activin Receptor-like Kinase (ALK)1 Is an Antagonistic Mediator of Lateral TGFβ/ALK5 SignalingMolecular Cell, 2003